Drugs for malaria and psychosis may offer hope to people with CJDBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7310.416b (Published 25 August 2001) Cite this as: BMJ 2001;323:416
- Deborah Josefson
- San Francisco
Doctors at the University of California in San Francisco are starting clinical trials for Creutzfeldt-Jakob disease (CJD) and variant CJD (vCJD) with quinacrine and chlorpromazine, after finding that the drugs inhibited the propagation of prions in a mouse neuroblastoma cell culture line (Proceedings of the National Academy of Sciences 2001;98:9836-41.).
News media have disclosed that two patients have already begun treatment and that one of them, Rachel Forber, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial